APYX
insider transactionsApyx Medical Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Operating Officer
$0
15.0K sh
Own New
-
Other·F
Chief Operating Officer
$48.5K
10.5K sh · $4.60
Own -39%
-
Exercise·M
Chief Operating Officer
$48.5K
15.0K sh · $3.23
Own New
-
Grant·A
Director
$0
50.0K sh
Own New
-
Grant·A
Director
$0
450.0K sh
Own +26%
-
Grant·A
Chief Executive Officer
$0
213.9K sh
Own New
-
Grant·A
Chief Operating Officer
$0
88.0K sh
Own New
-
Grant·A
Director
$0
50.0K sh
Own New
-
Grant·A
Director
$0
50.0K sh
Own New
-
Grant·A
HILL MATTHEW C KEY
Chief Financial Officer
$0
132.1K sh
Own New
-
Grant·A
Sr. V.P. of Operations
$0
63.4K sh
Own New
-
Exercise·M
Senior Vice President
$0
37.0K sh
Own New
-
Exercise·M
Senior Vice President
$66.6K
37.0K sh · $1.80
Own +8%
-
Exercise·M
Chief Operating Officer
$0
12.0K sh
Own New
-
Exercise·M
Chief Operating Officer
$21.6K
12.0K sh · $1.80
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Roman Shawn David | Exercise M | 15.0K | $0 |
| Jun 15, 2026 | Roman Shawn David | Other F | 10.5K | $48.5K |
| Jun 15, 2026 | Roman Shawn David | Exercise M | 15.0K | $48.5K |
| Jun 11, 2026 | Levine Wendy Lauren | Grant A | 50.0K | $0 |
| Jun 11, 2026 | Vizirgianakis Stavros G. | Grant A | 450.0K | $0 |
| Jun 11, 2026 | Goodwin Charles D. II KEY | Grant A | 213.9K | $0 |
| Jun 11, 2026 | Roman Shawn David | Grant A | 88.0K | $0 |
| Jun 11, 2026 | Baylor-Henry Minnie | Grant A | 50.0K | $0 |
| Jun 11, 2026 | Waldman Lawrence | Grant A | 50.0K | $0 |
| Jun 11, 2026 | HILL MATTHEW C KEY | Grant A | 132.1K | $0 |
| Jun 11, 2026 | CITRONOWICZ MOSHE | Grant A | 63.4K | $0 |
| Mar 15, 2026 | CITRONOWICZ MOSHE KEY | Exercise M | 37.0K | $0 |
| Mar 15, 2026 | CITRONOWICZ MOSHE KEY | Exercise M | 37.0K | $66.6K |
| Jan 27, 2026 | Roman Shawn David | Exercise M | 12.0K | $0 |
| Jan 27, 2026 | Roman Shawn David | Exercise M | 12.0K | $21.6K |
About APYX insider trading
This page tracks insider transactions for Apyx Medical Corp (APYX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.